XKRX:226950 (Korea (the Republic of))
Â
Ordinary Shares
â‚©
15700.00
(+1.62%)
Jan 10
Business Description
OliX Pharmaceuticals Inc
ISIN : KR7226950004
Share Class Description:
XKRX:226950: Ordinary SharesCompare
Compare
Traded in other countries / regions
226950.Korea IPO Date
2018-07-18Description
OliX Pharmaceuticals Inc is a clinical stage biotechnology company. It is engaged in developing RNA interference (RNAi) technology therapeutics for dermal, ophthalmic and pulmonary diseases. The company's pipeline products include OLX101, OLX201, OLX301, OLX102, and others.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.25 | |||||
| Equity-to-Asset | 0.19 | |||||
| Debt-to-Equity | 2.99 | |||||
| Debt-to-EBITDA | -2.48 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -1.1 | |||||
| Beneish M-Score | -2.28 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 84.6 | |||||
| 3-Year EBITDA Growth Rate | 16.9 | |||||
| 3-Year EPS without NRI Growth Rate | 0.3 | |||||
| 3-Year FCF Growth Rate | -77.6 | |||||
| 3-Year Book Growth Rate | -2.7 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 29.5 | |||||
| 9-Day RSI | 33.45 | |||||
| 14-Day RSI | 36.96 | |||||
| 6-1 Month Momentum % | 171.01 | |||||
| 12-1 Month Momentum % | 50.6 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.42 | |||||
| Quick Ratio | 0.4 | |||||
| Cash Ratio | 0.32 | |||||
| Days Sales Outstanding | 31.16 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5.8 | |||||
| Shareholder Yield % | -0.36 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -130.38 | |||||
| Net Margin % | -156.78 | |||||
| FCF Margin % | -216.74 | |||||
| ROE % | -74.78 | |||||
| ROA % | -26.21 | |||||
| ROIC % | -23.25 | |||||
| 3-Year ROIIC % | -6.08 | |||||
| ROC (Joel Greenblatt) % | -48.14 | |||||
| ROCE % | -30.5 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 15.78 | |||||
| PB Ratio | 16.71 | |||||
| Price-to-Tangible-Book | 18.71 | |||||
| EV-to-EBIT | -13.87 | |||||
| EV-to-EBITDA | -15.74 | |||||
| EV-to-Revenue | 19.07 | |||||
| EV-to-FCF | -8.8 | |||||
| Earnings Yield (Greenblatt) % | -7.21 | |||||
| FCF Yield % | -12.92 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
OliX Pharmaceuticals Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 16,137.926 | ||
| EPS (TTM) (â‚©) | -1430 | ||
| Beta | -0.77 | ||
| Volatility % | 96.23 | ||
| 14-Day RSI | 36.96 | ||
| 14-Day ATR (â‚©) | 1821.137435 | ||
| 20-Day SMA (â‚©) | 19064 | ||
| 12-1 Month Momentum % | 50.6 | ||
| 52-Week Range (â‚©) | 8280 - 32750 | ||
| Shares Outstanding (Mil) | 17.24 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
OliX Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
OliX Pharmaceuticals Inc Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
OliX Pharmaceuticals Inc Frequently Asked Questions
What is OliX Pharmaceuticals Inc(XKRX:226950)'s stock price today?
The current price of XKRX:226950 is â‚©15700.00. The 52 week high of XKRX:226950 is â‚©32750.00 and 52 week low is â‚©8280.00.
When is next earnings date of OliX Pharmaceuticals Inc(XKRX:226950)?
The next earnings date of OliX Pharmaceuticals Inc(XKRX:226950) is 2025-02-14 Est..
Does OliX Pharmaceuticals Inc(XKRX:226950) pay dividends? If so, how much?
OliX Pharmaceuticals Inc(XKRX:226950) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers